1996
Serial myocardial perfusion imaging with Tc-99m-labeled myocardial perfusion imaging agents in patients receiving thrombolytic therapy for acute myocardial infarction
Wackers F. Serial myocardial perfusion imaging with Tc-99m-labeled myocardial perfusion imaging agents in patients receiving thrombolytic therapy for acute myocardial infarction. Developments In Cardiovascular Medicine 1996, 173: 1-12. DOI: 10.1007/978-94-009-0115-5_1.Peer-Reviewed Original ResearchAcute myocardial infarctionThrombolytic therapyMyocardial infarctionInfarct arteryMyocardial perfusionRecurrent myocardial infarctionInfarct artery patencyLong-term mortalityAppropriate adjunctive therapyNovel treatment strategiesTerm mortalityAdjunctive therapyArtery patencyAcute infarctionHibernating myocardiumConventional therapyUnfavorable outcomeAntithrombotic agentsTreatment strategiesComparative efficacyReocclusionPatientsInfarctionTherapyBeneficial effects
1990
Thrombolytic therapy for myocardial infarction: Assessment of efficacy by myocardial perfusion imaging with technetium-99m sestamibi
Wackers F. Thrombolytic therapy for myocardial infarction: Assessment of efficacy by myocardial perfusion imaging with technetium-99m sestamibi. The American Journal Of Cardiology 1990, 66: e36-e41. PMID: 2145744, DOI: 10.1016/0002-9149(90)90610-d.Peer-Reviewed Original ResearchConceptsRecombinant tissue-type plasminogen activatorThrombolytic therapyMyocardial infarctionFirst acute myocardial infarctionInfarct-related artery patencyInitial risk areaPersistent coronary occlusionAcute chest painAcute myocardial infarctionAssessment of efficacyFuture clinical researchImaging agentNew thrombolytic agentsTissue-type plasminogen activatorArtery patencyChest painInfarct arterySuccessful thrombolysisConventional therapyCoronary occlusionHypoperfused myocardiumThrombolytic agentsMyocardial perfusionPatientsEnd point